Arcturus Therapeutics Holdings Inc (ARCT)

Arcturus (ARCT) Q1 2026 Earnings Call Transcript

The widely followed investor has been buying stocks trading well below their all-time highs.

The growing investing icon was skimpy on her purchases last week, making the names she did buy that much more interesting.

Arcturus (ARCT) Q4 2025 Earnings Call Transcript

Arcturus Q3 2025 results show a revenue miss but a smaller-than-expected loss. The company advances its CF and OTC programs, with cash extending into 2028.

The growth-focused money manager only bought three stocks on Wednesday. Let's check out that shopping list.

Arcturus stock drops on interim Phase 2 results for ARCT-032, showing promising mucus reduction in cystic fibrosis patients but no initial FEV₁ improvement.

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Let's have a look at the gap up and gap down stocks in today's session.

The company said that treatment-related adverse events were observed in the study for the first few doses but ceased with continuous dosing.

The company is working on a treatment for cystic fibrosis using messenger RNA, or mRNA, technology.

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.